Orphan designation: Sorafenib tosilate Treatment of papillary thyroid cancer, 13/11/2013 Expired | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 7 June 2024 - 13:58

Orphan designation: Sorafenib tosilate Treatment of papillary thyroid cancer, 13/11/2013 Expired

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-13-1200

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters